Omarion Pharmaceuticals Private Limited

Omarion Pharmaceuticals Private Limited - paper in Dadri, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U21001UP2023PTC187075 Incorporated 09 August 2023 ROC Kanpur HQ Dadri, Uttar Pradesh, India
Active Private Limited Company paper
Data last updated
Revenue · FY 2025
₹68.06 Lakh
Latest filing
Net profit · FY 2025
₹42,423
Net margin 0.6%
EBITDA · FY 2025
₹93,379
EBITDA margin 1.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Omarion Pharmaceuticals Private Limited

Data last updated:

Omarion Pharmaceuticals Private Limited is a private limited company based in Dadri, Uttar Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 09 August 2023.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U21001UP2023PTC187075.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Niyati Jain Agarwal and Neha Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dadri, Uttar Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹68.06 Lakh. For the same year it recorded a net profit of ₹42,423 (net margin 0.6%) and EBITDA of ₹93,379 (EBITDA margin 1.4%).

Company details

CIN U21001UP2023PTC187075
Registration Number 187075
Incorporation Date 09 August 2023
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Omarion Pharmaceuticals Private Limited's registered office is in Dadri, Uttar Pradesh.

  • Registered Address
    Lg – 004 Site 4 Kasna, Gretar Noida, Dadri, Uttar Pradesh, India – 201310
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Comprehensive company report
Omarion Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Omarion Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Omarion Pharmaceuticals Private Limited, buy the company report.

Financials of Omarion Pharmaceuticals Private Limited

FY 2025 filings available

Omarion Pharmaceuticals Private Limited reported revenue of ₹68.06 Lakh for FY 2025.

Revenue · FY 2025
₹68.06 Lakh
Net profit · FY 2025
₹42,423 margin 0.6%
EBITDA · FY 2025
₹93,379 margin 1.4%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹93,379
Profit Before Tax
Tax Expense
Net Profit (PAT)₹42,423
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin1.4%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Omarion Pharmaceuticals Private Limited, buy the company report.

Board of directors of Omarion Pharmaceuticals Private Limited

Omarion Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Niyati Jain AgarwalDirector09 Aug 20233 Years 2 MonthsCurrent
Neha SharmaDirector09 Aug 20233 Years 2 MonthsCurrent
Harshit AgarwalIndividual Subscriber09 Aug 20233 Years 2 MonthsCurrent
Rohit AgarwalIndividual Subscriber09 Aug 20233 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Omarion Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Omarion Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Omarion Pharmaceuticals Private Limited has 5 board changes on record since 2023: 4 appointments and 1 cessation. The latest: Rohit Agarwal ceased to be Additional Director on 21 Nov 2024.

AGM
Omarion Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Omarion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Rohit Agarwal ceased to be Additional Director.
Appointed
Harshit Agarwal was appointed as Individual Subscriber.
Appointed
Neha Sharma was appointed as Director.
Appointed
Niyati Jain Agarwal was appointed as Director.
Appointed
Rohit Agarwal was appointed as Individual Subscriber.
Incorporation
09 Aug 2023
Omarion Pharmaceuticals Private Limited was registered on 09 Aug 2023 with Roc Kanpur & aged 3 years 2 months as per MCA records.

Frequently asked questions

Omarion Pharmaceuticals is an active private limited company based in Dadri, Uttar Pradesh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 09 August 2023 (3+ years old) and is registered under CIN U21001UP2023PTC187075.

Omarion Pharmaceuticals has 4 current directors:

The latest financial statements of Omarion Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Omarion Pharmaceuticals is U21001UP2023PTC187075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Omarion Pharmaceuticals was incorporated on 09 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.

Rohit Agarwal ceased to be Additional Director on 21 Nov 2024. Harshit Agarwal was appointed as Individual Subscriber on 09 Aug 2023. Neha Sharma was appointed as Director on 09 Aug 2023. Omarion Pharmaceuticals has 5 board changes on record in total.

The registered office of Omarion Pharmaceuticals is at Lg – 004 Site 4 Kasna, Gretar Noida, Dadri, Uttar Pradesh, India – 201310.

Omarion Pharmaceuticals operates in the paper industry, in the paper and paper products segment.

Omarion Pharmaceuticals can be reached at its registered office: Lg – 004 Site 4 Kasna, Gretar Noida, Dadri, Uttar Pradesh, India – 201310.

Omarion Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.